Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.

Silenor® is the company’s lead marketed product. Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance, and has been commercially available by prescription in the ...

Contact Information

3570 Carmel Mountain Road, Suite 100
San Diego, CA 92130

tel: 858-480-0400
fax: 858-509-1761


Investor Relations

e-mail: investors@somaxon.com


Exchange: NASDAQ
Industry: Drug Manufacturers - Other
Market Cap: $76M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.